Consolidated Statements of Cash Flows (USD $)	5 Months Ended	12 Months Ended
Consolidated Statements of Cash Flows (USD $)	Jul. 31, 2011	Jul. 31, 2012
Cash flows from operating activities:
Net income (loss)	$ (699,871)	$ (2,737,499)
Increase (decrease) in derivative liability		(315)
Initial expense on derivative liabilities		130,687
Stock based compensation		1,577,022
Common stock issued for services	439,580	1,500
Cash acquired in merger		152
Amortization of discount on debentures payable		(202,417)
Amortization of debt issuance costs		18,631
Beneficial conversion feature		223,776
Depreciation		704
Impairment of investment in subsidiary		25,000
Increase in accounts receivable		(44,491)
Increase in inventory		(13,159)
Decrease in prepaid expenses and other current assets	(22,500)	22,500
Increase in accounts payable and accrued expenses	69,006	282,156
Decrease in amounts due to related parties		(46,525)
Net cash used in operating activities	(213,785)	(357,444)
Cash flows from investing activities:
Purchase of property and equipment	(704)
Net cash used in investing activities	(704)
Cash flows from financing activities:
Proceeds from sale of common stock	263,000	5,000
Proceeds from issuance of related party notes payable	8,000	10,400
Proceeds from issuance of notes payable		100,000
Proceeds from issuance of debentures payable		216,000
Placement fees paid		(15,000)
Repayments of notes payable	(7,500)	(500)
Net cash provided by financing activities	263,500	315,900
Net increase (decrease) in cash and cash equivalents	49,011	(41,544)
Cash and cash equivalents, beginning of period		49,011
Cash and cash equivalents, end of period	49,011	7,467
Supplemental disclosures of cash flow information:
Cash paid during the year for interest		5,835
Cash paid during the year for taxes
Non-cash investing and financial activities:
Fair value of options and shares issued for services	439,580	1,578,522
Fair value of shares of common stock issued for debentures and accrued and unpaid interest		288,236
Fair value of shares of common stock issued for account payable		$ 43,007

SURGLINE INTERNATIONAL, INC. 10-K